Literature DB >> 21785118

Drug interaction of levothyroxine with infant colic drops.

Mihirani Balapatabendi1, David Harris, Savitha D Shenoy.   

Abstract

Infacol (Forest Laboratories UK, Kent, UK) is a widely available over-the-counter preparation used to relieve colic symptoms in neonates and infants. The active ingredient is simeticone. No drug interactions with simeticone are documented in the current summary of product characteristics. The authors report the case of an infant with confirmed congenital hypothyroidism on levothyroxine who experienced a possible drug interaction with simeticone. Despite adequate levothyroxine dosage, thyroid stimulating hormone (TSH) was high, suggesting undertreatment. Questioning revealed the child was taking Infacol drops before feeds while on levothyroxine. The colic drops were immediately discontinued and TSH promptly normalised with a reduction in thyroxine requirement to an age appropriate dosage. Drug interaction of thyroxine with simeticone has not been reported previously and is not listed in the British National Formulary for Children. Clinicians and parents need to be aware of this interaction to avoid unnecessary undertreatment and prevent potential long-term neurological sequelae.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21785118     DOI: 10.1136/archdischild-2011-300333

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  5 in total

Review 1.  Congenital hypothyroidism and the importance of universal newborn screening.

Authors:  Firas A Salim; Surendra K Varma
Journal:  Indian J Pediatr       Date:  2013-12-11       Impact factor: 1.967

2.  Guidelines for the treatment of hypothyroidism: prepared by the american thyroid association task force on thyroid hormone replacement.

Authors:  Jacqueline Jonklaas; Antonio C Bianco; Andrew J Bauer; Kenneth D Burman; Anne R Cappola; Francesco S Celi; David S Cooper; Brian W Kim; Robin P Peeters; M Sara Rosenthal; Anna M Sawka
Journal:  Thyroid       Date:  2014-12       Impact factor: 6.568

3.  Treating congenital hypothyroidism--which levothyroxine?

Authors:  Johnny Deladoëy; Guy Van Vliet
Journal:  Nat Rev Endocrinol       Date:  2013-03-05       Impact factor: 43.330

Review 4.  Congenital Anomalies in Infant With Congenital Hypothyroidism: A Review of Pathogenesis, Diagnostic Options, and Management Protocols.

Authors:  Kivonika Uthayaseelan; Monika Kadari; Muhammad Subhan; Nisha Saji Parel; Parimi Vamsi Krishna; Anuradha Gupta; Kamsika Uthayaseelan
Journal:  Cureus       Date:  2022-05-02

Review 5.  An Overview on Different L-Thyroxine (l-T4) Formulations and Factors Potentially Influencing the Treatment of Congenital Hypothyroidism During the First 3 Years of Life.

Authors:  Stefano Stagi; Giovanna Municchi; Marta Ferrari; Malgorzata Gabriela Wasniewska
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-09       Impact factor: 6.055

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.